Investment Thesis
FormFactor maintains fortress-like financial health with exceptional balance sheet strength (0.01x debt-to-equity), robust liquidity, and positive free cash flow generation. However, net income declined 21.9% year-over-year despite 2.8% revenue growth, signaling operational deterioration and very weak returns on capital (ROE 1.9%, ROA 1.6%) that require reversal before investment conviction.
Strengths
- Exceptional balance sheet with minimal leverage (0.01x D/E ratio) and $123.5M cash reserves providing substantial financial flexibility
- Outstanding liquidity position (4.55x current ratio, 3.69x quick ratio) with strong interest coverage (32.0x) ensures no solvency concerns
- Consistent free cash flow generation of $29.8M (13.2% FCF margin) demonstrates cash-generative business model despite profitability headwinds
Risks
- Significant profitability decline of 21.9% net income YoY despite modest 2.8% revenue growth indicates deteriorating operational efficiency or margin compression
- Critically low returns on equity (1.9%) and assets (1.6%) reveal inefficient capital deployment and poor asset utilization across the business
- Modest revenue growth in capital-intensive semiconductor test equipment sector facing cyclical headwinds and competitive pressures
Key Metrics to Watch
- Operating margin trends and ability to improve operational efficiency
- Revenue growth acceleration and market share dynamics in wafer probing/inspection markets
- Return on equity improvement and whether company can deploy capital more effectively
Financial Metrics
Revenue
226.1M
Net Income
20.4M
EPS (Diluted)
$0.26
Free Cash Flow
29.8M
Total Assets
1.3B
Cash
123.5M
Profitability Ratios
Gross Margin
38.4%
Operating Margin
7.4%
Net Margin
9.0%
ROE
1.9%
ROA
1.6%
FCF Margin
13.2%
Balance Sheet & Liquidity
Current Ratio
4.55x
Quick Ratio
3.69x
Debt/Equity
0.01x
Debt/Assets
15.7%
Interest Coverage
31.95x
Long-term Debt
10.8M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T15:13:29.282124 |
Data as of: 2026-03-28 |
Powered by Claude AI